Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

A role for exogenous GLP-1 in the management of postprandial hypoglycaemia after Roux-en-Y gastric bypass?

Research output: Contribution to journalComment/debateResearchpeer-review

DOI

  1. Risk of over- And under- treatment with levothyroxine in primary care in Copenhagen, Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Risk factors for hyperglycemia in pregnancy in the DALI study differ by period of pregnancy and OGTT time point

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. THERAPY OF ENDOCRINE DISEASE: Growth hormone replacement therapy in adults: 30 years of personal clinical experience

    Research output: Contribution to journalReviewResearchpeer-review

  4. EJE PRIZE 2018: A gut feeling about glucagon

    Research output: Contribution to journalReviewResearchpeer-review

  5. Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Beta-hydroxybutyrate suppresses hepatic production of the ghrelin receptor antagonist, LEAP2

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. THERAPY OF ENDOCRINE DISEASE: Amylin and calcitonin - physiology and pharmacology

    Research output: Contribution to journalReviewResearchpeer-review

  3. LEAP2 reduces postprandial glucose excursions and ad libitum food intake in healthy men

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Long-acting amylin analogues for the management of obesity

    Research output: Contribution to journalReviewResearchpeer-review

  5. Gastric Aspiration Improves Postprandial Glucose Tolerance Without Causing a Compensatory Increase in Appetite and Food Intake

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Roux-en-Y gastric bypass (RYGB) is one of the most common bariatric surgeries. The procedure induces a sustained weight loss together with a reduction in obesity-related comorbidities including type 2 diabetes. The effects on postprandial glucose metabolism are evident within days or weeks after surgery - before any weight loss has occurred - and are thought to be achieved by a faster passage of nutrients to the small intestine and ensuing alterations in the secretion of several gastrointestinal hormones, acceleration of glucose absorption and increased insulin secretion. Especially the remarkable increase in postprandial plasma levels of the gut-derived incretin hormone glucagon-like peptide 1 (GLP-1) - with not only a potent insulinotropic effect, but also a glucagonostatic effect - is believed to contribute to the metabolic improvements and the early remission of type 2 diabetes seen after RYGB.

Original languageEnglish
JournalEuropean Journal of Endocrinology
Volume181
Issue number3
Pages (from-to)5-8
Number of pages4
ISSN0804-4643
DOIs
Publication statusPublished - Jul 2019

ID: 58138553